Poor
Not Aligned
Patient Risk:
Medium
Summary
The claims concern Cosentyx storage/time-out-of-refrigeration limits, but the supplied FDA label excerpts do not include any storage/handling time-out-of-fridge or room-temperature duration information. These claims are therefore unsupported based on the provided labeling.
Category Scores
Accurate Statements
Unsupported Statements
Cosentyx (secukinumab) should be stored refrigerated at 2°C to 8°C.
The provided FDA label excerpts do not include storage/handling temperature requirements (no storage section text provided).
When traveling or during use, Cosentyx can be kept at room temperature for a limited time before it must be returned to refrigeration.
The provided FDA label excerpts do not include any room-temperature limit or time-out-of-refrigeration instructions.
The manufacturer’s allowed time out of the fridge for Cosentyx depends on the specific presentation (e.g., pre-filled syringe, Sensoready pen).
No label excerpt provided addresses presentation-specific room-temperature/time-out-of-refrigeration limits.
The allowed time out of the fridge is defined in the prescribing information or product label.
While generally plausible, the supplied excerpts contain no statement defining time-out-of-fridge limits in the label content provided.
The storage section of the prescribing information/label specifies an amount of time (e.g., up to X days at room temperature) and may include conditions such as protection from light.
No storage/handling section text (including time at room temperature or protection from light) is included in the provided excerpts.
If Cosentyx is kept out longer than the labeled room-temperature limit, the manufacturer advises not using doses that have been stored outside the specified conditions.
The provided excerpts do not include any guidance about not using doses stored beyond labeled conditions.
Contradictions
Important Omissions
Label-based storage/handling instructions (temperature range, allowed room-temperature duration, presentation-specific limits, and any conditions such as protection from light) and what to do if limits are exceeded.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
These claims could affect product integrity and effective dosing, but they cannot be verified against the provided labeling excerpts because storage/handling information is not included.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Storage/handling and time-out-of-refrigeration details are not supported by the provided FDA label excerpts.
Suggested Improvement
Remove or revise the storage/time-out-of-fridge claims unless the exact FDA label storage/handling section text (including temperature, allowed room-temperature duration by presentation, and instructions if limits are exceeded) is provided and cited.